Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Jul 29;10(1):3394.
doi: 10.1038/s41467-019-11382-8.

Development of bifunctional organocatalysts and application to asymmetric total synthesis of naucleofficine I and II

Affiliations

Development of bifunctional organocatalysts and application to asymmetric total synthesis of naucleofficine I and II

Yong-Hai Yuan et al. Nat Commun. .

Abstract

The proline-type organocatalysts has been efficiently employed to catalyze a wide range of asymmetric transformations; however, there are still many synthetically useful and challenging transformations that remain unachievable in an asymmetric fashion. Herein, a chiral bifunctional organocatalyst with a spirocyclic pyrrolidine backbone-derived containing fluoro-alkyl and aryl sulfonamide functionalities, are designed, prepared, and examined in the asymmetric Mannich/acylation/Wittig reaction sequence of 3,4-dihydro-β-carboline with acetaldehyde, acyl halides, and Wittig reagents. As a result, the spirocyclic pyrrolidine trifluoromethanesulfonamide catalyst can facilitate this versatile sequence as demonstrated by 18 examples displaying excellent enantioselectivity (up to 94% ee), as well as moderate to good yields (up to 54% over 3 steps). As a practical application, the asymmetric total synthesis of naucleofficine I (1a) and II (1b) in ten steps have been accomplished.

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing interests.

Figures

Fig. 1
Fig. 1
Design of asymmetric synthesis of monoterpenoid alkaloids. Retro-synthesis involves Diels–Alder reaction and Mannich/acylation/Wittig sequent reaction
Fig. 2
Fig. 2
The substrate scope of the Mannich/Acylation/Wittig reaction. Reaction condition: 2a (0.1 mmol), acetaldehyde (0.3 mmol), (S,S)-Cat 1 (0.02 mmol), and Et3N (0.05 mmol), in 0.5 mL DCE and 0.5 mL H2O, then acyl halide 3 (0.15 mmol) and Wittig reagent 4 (0.2 mmol). Isolated yield over three steps. Enantiomeric excess determined by HPLC analysis. a The scope of 3,4-dihydro-β-carboline substrates. b The scope of 3,4-dihydro-isoquinoline substrates
Fig. 3
Fig. 3
Further transformation. Thermocatalytic hetero-Diels–Alder reaction mainly obtained the cis-product of C3 and C15
Fig. 4
Fig. 4
Gram-scale synthesis of 5o. Reactions were performed with 10% mol (R,R)-Cat 1
Fig. 5
Fig. 5
Asymmetric total synthesis of naucleofficine I and II. The key steps include O-hetero-Diels–Alder cycloaddition, hydroformylation, and double bond isomerization

Similar articles

Cited by

References

    1. Ishikawa H, Suzuki T, Hayashi Y. High-yielding synthesis of the anti-influenza neuramidase inhibitor (–)-Oseltamivir by three “One-Pot” operations. Angew. Chem. Int. Ed. 2009;48:1304–1307. doi: 10.1002/anie.200804883. - DOI - PubMed
    1. Jones SB, Simmons B, Mastracchio A, MacMillan DW. Collective synthesis of natural productsby means of organocascade catalysis. Nature. 2011;475:183–188. doi: 10.1038/nature10232. - DOI - PMC - PubMed
    1. Xu X-Y, et al. Asymmetric organocatalytic direct aldol reactions of ketones with α-keto acids and their application to the synthesis of 2-hydroxy-γ-butyrolactones. J. Org. Chem. 2007;72:9905–9913. doi: 10.1021/jo701868t. - DOI - PubMed
    1. Torii H, Nakadai M, Ishihara K, Saito S, Yamamoto H. Asymmetric direct aldol reaction assisted by water and a proline‐derived tetrazole catalyst. Angew. Chem. Int. Ed. 2004;43:1983–1986. doi: 10.1002/anie.200352724. - DOI - PubMed
    1. Albrecht L, Jiang H, Jørgensen KA. Hydrogen‐bonding in aminocatalysis: from proline and beyond. Chem. Eur. J. 2014;20:358–368. doi: 10.1002/chem.201303982. - DOI - PubMed

Publication types